The a2 Milk Co Ltd
ATM: XNZE (NZL)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
NZD 3.00 | Kwkqxk | Yxyjtxlr |
U.S. Infant Formula Approval Is a Bonus for a2 Milk, but China Remains Crucial
A2 Milk has been handed its best shot yet to break into the U.S. infant formula market with temporary access to the market granted by the U.S. Food and Drug Administration. Despite receiving notification from the FDA on Aug. 10 that its application to plug the ongoing infant formula shortage is on ice, a2 continued to meet the FDA requirements and has now been approved to sell stage 1 and 2 infant formula through Jan. 6, 2023. Under certain conditions, this could be extended to Oct. 18, 2025.